Lonnie Moulder

Ex­clu­sive: Two M&A deals and $9B lat­er, Lon­nie Moul­der is ramp­ing up his lat­est biotech start­up. And this one comes with glob­al vi­sion built in

Lon­nie Moul­der may have been in silent run­ning mode in the 2 years since he closed the $5 bil­lion sale of Tesaro to Glax­o­SmithK­line …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.